Delivery Order SPE2DB24D2212-SPE2DB25FHQKM
- Not listed
- The Defense Logistics Agency awarded a $13,817.08 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed price contract was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $26,582.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded with no set-aside designation and is set for completion by August 4, 2025. This delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $8,409.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The competitively awarded, firm fixed-price delivery order was placed on August 8, 2025, with an ultimate completion date of August 11, 2025. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,507.26 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, awarded on May 30, 2025, with completion scheduled for June 2, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will occur at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $36,809.08 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. Awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, this firm fixed-price delivery order represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a Delivery Order valued at $16,547.64 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder used for chronic obstructive pulmonary disease management. The competitively awarded contract, which was not set aside for any specific business category, is firm fixed price and was executed on September 11, 2025, with an ultimate completion date of September 12, 2025. The product will be performed and delivered from...
- The Defense Logistics Agency awarded a delivery order valued at $14,019.75 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,847.34 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used in the treatment of chronic obstructive pulmonary disease. This firm fixed price delivery order, issued on August 5, 2025, represents a single transaction under a larger contract vehicle. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $12,609.36 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, issued on August 26, 2025, represents a non-competitive award under the company's existing contract vehicle and is scheduled for completion by August 27, 2025. Performance will be conducted at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $2,826.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price delivery order, issued on July 18, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania,...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQKMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,257.40 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This firm fixed price delivery order, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support to Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. The IDC enables AmerisourceBergen to deliver a broad spectrum of pharmaceutical products across multiple therapeutic domains to support military and federal healthcare programs, with individual delivery orders like this one fulfilling specific medication requirements within the broader framework of the global pharmaceutical support agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 7/30/25 |